Start
Features
Free trial / FAQ

Researchers
Physicians
Pharmacists
Ecotrophologists
Product Managers
in Health Industries

Loading…

Medical Research Finder

Legal Notice
Privacy
Terms of Use

meRfi® Microbiome - The Digital Gut Microbiome Reference (incl. AI Chat)
Prebiotics, Probiotics, FMT / Manipulators of the Intestinal Microbiota

AuthorsReferences (Sources)

meRfi® AI Chat

Prucalopride & Functional constipation / Chronic Idiopathic Constipation

Welcome to meRfi Microbiome!

Please register to continue your trial period!

meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.

Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.

Start your free trial and transform your understanding of the gut microbiota today!

(Login)

Navigation

In the context of Prucalopride & Chronic constipation, Prucalopride is approved by both FDA and EMA for adults with chronic idiopathic constipation (CIC), i.e. chronic constipation without an identifiable secondary cause (1, 2, 3, 4, 5)

References:

(1) Mahajan 2019 Int J Appl Basic Med Res 9(1): 1-2
(2) Tameez et al. 2019 Cureus 11(4): e4382
(3) Stevens et al. 2013
(4) Quigley 2012 Therap Adv Gastroenterol. 5(1): 23-30.
(5) Hong 2021 Ther Clin Risk Manag 17: 601-615

…

References (Sources)

Clinical Efficacy and Safety Profile of Prucalopride in Chronic Idiopathic Constipation
Tameez et al. 2019 Cureus 11(4): e4382
Current Opinion on Prucalopride in Gastroparesis and Chronic Constipation Treatment: A Focus on Patient Selection and Safety
Hong 2021 Ther Clin Risk Manag 17: 601-615
Review
Pathophysiology and pharmacotherapy of gastroparesis: current and future perspectives
Stevens et al. 2013
Review
Prucalopride: A Recently Approved Drug by the Food and Drug Administration for Chronic Idiopathic Constipation
Mahajan 2019 Int J Appl Basic Med Res 9(1): 1-2
Prucalopride: safety, efficacy and potential applications.
Quigley 2012 Therap Adv Gastroenterol. 5(1): 23-30.

AI Chat

7/1/2026

Chat with our artificial intelligence:

Start chat!